Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance

Revenues of $1.007 Billion



GAAP Net Loss Attributable to Bausch + Lomb Corporation of $84 Million



Adjusted EBITDA 1 of $187 Million



Revenues Grew 7% as Reported and 8% on a Constant...

Related Keywords

Ireland ,New Jersey ,United States ,Canada ,Canadian ,America ,Brent Saunders ,Canada Revenue Agency ,Audit Committee ,Revenue Service ,Linkedin ,Pharmaceuticals Segment ,Instagram ,Lomb Corporation To ,Bausch Health Companies Inc ,Exchange Commission ,Lomb Corporation ,International Pharmaceuticals ,Twitter ,Facebook ,Lomb Corporation To Adjusted Net Income ,Intermediate Optimized ,Eye Vitamins ,Sihy Daily ,Business Transformation Costs ,Per Share ,Forward Looking Statements ,Event Dial In ,North America ,Access Code ,Canadian Securities Administrators ,Annual Report ,Bausch Health Companies ,Internal Revenue Service ,Net Income ,Constant Currency ,Vision Care ,Nine Months Ended September ,Share Attributable ,Adjusted Net Income ,Adjusted Earnings Per Share ,Months Ended September ,Currency Revenue ,Constant Currency Revenue Growth ,Constant Currency Revenue ,Three Months ,Nine Months ,Markets ,